<searchTitle>Memorandum of Understanding With Duke University; Federal Register Vol. 74, Issue </searchTitle>
<granuleClass>NOTICE</granuleClass>
<accessId>E9-22001</accessId>
<agency order="1">DEPARTMENT OF HEALTH AND HUMAN SERVICES</agency>
<agency order="2">Food and Drug Administration</agency>
<effectiveDate>2009-08-04</effectiveDate>
<departmentDoc>Docket No. FDA-2009-N-0667</departmentDoc>
<departmentDoc>FDA 225-09-0010</departmentDoc>
<billingCode>4160-01-S</billingCode>
<frDocNumber>E9-22001</frDocNumber>
<action>Notice.</action>
<summary>The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Food and Drug Administration and Duke University. The purpose of this MOU is to establish a framework for collaboration between the Parties and for pursuing specific collaborative projects. This collaboration between the Parties shall be known as the Cardiac Safety Research Consortium.</summary>
<dates>The agreement became effective August 4, 2009.</dates>
<contact>Wendy R. Sanhai, Office of the Commissioner (HZ-1), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7867, FAX: 301-827-5891.</contact>
<tocDoc>Memorandum of Understanding with Duke University
, </tocDoc>